Learned by Reading
In the ICWSM 2009 Weblog Corpus:
Some also bind to foreign antigens and present them to immune cells.
(Parse)
(S1 (S (NP (DT Some)) (ADVP (RB also))
(VP (VP (NN bind)
(PP (TO to)
(NP (JJ foreign) (NNS antigens))))
(CC and)
(VP (VB present)
(NP (PRP them))
(PP (TO to)
(NP (JJ immune) (NNS cells)))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Much like soldiers who grow weary in battle, your immune cells can also lose some of their protective effects when your body is constantly battling poor health habits.
(Parse)
(S1 (S (PP (ADVP (RB Much)) (IN like)
(NP (NP (NNS soldiers))
(SBAR (WHNP (WP who))
(S (VP (VBP grow)
(ADJP (JJ weary))
(PP (IN in)
(NP (NN battle)))))
(, ,)
(NP (PRP$ your) (JJ immune) (NNS cells))
(VP (MD can) (ADVP (RB also))
(VP (VB lose)
(NP (NP (DT some))
(PP (IN of)
(NP (PRP$ their) (JJ protective) (NNS effects))))
(SBAR (WHADVP (WRB when))
(S (NP (PRP$ your) (NN body))
(VP (AUX is) (ADVP (RB constantly))
(VP (VBG battling)
(NP (JJ poor) (NN health) (NNS habits)))))
(. .)))
In Wikipedia:
Other investigators examine the interaction between HIV and the immune cells it attacks in order to identify ways to prevent or interrupt the process by which the virus destroys the immune system.
(Parse)
(S1 (S (NP (JJ Other) (NNS investigators))
(VP (VB examine)
(NP (NP (DT the) (NN interaction))
(PP (IN between)
(NP (NP (NNP HIV)) (CC and)
(NP (NP (DT the) (JJ immune) (NNS cells))
(SBAR (S (NP (PRP it))
(VP (VBZ attacks)
(SBAR (IN in) (NN order)
(S (VP (TO to)
(VP (VB identify)
(NP (NP (NNS ways))
(SBAR (S (VP (TO to)
(VP (VB prevent) (CC or) (VB interrupt)
(NP (NP (DT the) (NN process))
(SBAR (WHPP (IN by) (WHNP (WDT which)))
(S (NP (DT the) (NN virus))
(VP (VBZ destroys)
(NP (DT the) (JJ immune) (NN system)))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Previous research has suggested that its not individual HIV viruses that get into the brain but rather HIV – infected immune cells known as monocytes, says Dr. Harris Goldstein, director of the Einstein – Montefiore Medical Center for AIDS Research and senior author of the study.
(Parse)
(S1 (SINV (S (NP (JJ Previous) (NN research))
(VP (AUX has)
(VP (VBN suggested)
(PP (PP (IN that)
(NP (NP (PRP$ its) (RB not) (JJ individual) (NNP HIV) (NNS viruses))
(SBAR (WHNP (WDT that))
(S (VP (VB get)
(PP (IN into)
(NP (DT the) (NN brain)))))
(CC but) (RB rather)
(NP (NNP HIV)))
(: -)
(NP (NP (JJ infected) (JJ immune) (NNS cells))
(VP (VBN known)
(PP (IN as)
(NP (NNS monocytes)))))
(, ,)
(VP (VBZ says))
(NP (NP (NNP Dr.) (NNP Harris) (NNP Goldstein)) (, ,)
(NP (NP (NP (NN director))
(PP (IN of)
(NP (NP (DT the) (NNP Einstein) (: -) (NNP Montefiore) (NNP Medical) (NNP Center))
(PP (IN for)
(NP (NNP AIDS) (NNP Research)))
(CC and)
(NP (NP (JJ senior) (NN author))
(PP (IN of)
(NP (DT the) (NN study)))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Antibodies that stick to ‘self’ cells can lead to activation of the complement system (your self cells explode), or tell other immune cells to eat your self cells, or the antibodies might actually mimic a chemical signal and activate receptors on your cells in a weird way!
(Parse)
(S1 (NP (NP (NP (NNS Antibodies))
(SBAR (WHNP (WDT that))
(S (VP (VBP stick)
(PP (TO to)))
(: ')
(S (S (NP (NP (NN self) (POS ')) (NNS cells))
(VP (MD can)
(VP (VP (VB lead)
(PP (TO to)
(NP (NP (NN activation))
(PP (IN of)
(NP (DT the) (VB complement) (NN system)))))
(PRN (-LRB- -LRB-)
(S (NP (PRP$ your) (NN self) (NNS cells))
(VP (VB explode)))
(-RRB- -RRB-)))
(, ,) (CC or)
(VP (VB tell)
(NP (JJ other) (JJ immune) (NNS cells))
(S (VP (TO to)
(VP (VB eat)
(NP (PRP$ your) (NN self) (NNS cells)))
(, ,) (CC or)
(S (NP (DT the) (NNS antibodies))
(VP (MD might) (ADVP (RB actually))
(VP (VP (VB mimic)
(NP (DT a) (JJ chemical) (NN signal)))
(CC and)
(VP (VBP activate)
(NP (NP (NNS receptors))
(PP (IN on)
(NP (PRP$ your) (NNS cells))))
(PP (IN in)
(NP (DT a) (JJ weird) (NN way)))))
(. !)))
In the ICWSM 2009 Weblog Corpus:
The drug, sold under the brand name Rituxan by Genentech and Biogen Idec Inc and as MabThera by Roche AG in Europe, suppresses the rogue immune cells that cause the condition, the researchers found.
(Parse)
(S1 (S (S (NP (NP (DT The) (NN drug)) (, ,)
(VP (VBN sold)
(PP (IN under)
(NP (NP (DT the) (NN brand) (NN name))
(NP (NNP Rituxan))))
(PP (PP (IN by)
(NP (NNP Genentech) (CC and) (NNP Biogen) (NNP Idec) (NNP Inc)))
(CC and)
(PP (IN as)
(NP (NNP MabThera))))
(PP (IN by)
(NP (NP (NNP Roche) (NNP AG))
(PP (IN in)
(NP (NNP Europe)))
(, ,))
(VP (VBZ suppresses)
(NP (NP (DT the) (JJ rogue) (JJ immune) (NNS cells))
(SBAR (WHNP (WDT that))
(S (VP (VBP cause)
(NP (DT the) (NN condition)))))
(, ,)
(NP (DT the) (NNS researchers))
(VP (VBD found)) (. .)))
In Wikipedia:
Immunotoxicity probably results from cell death following apoptosis and necrosis, in combination with slow replacement of affected immune cells due to inhibition of protein synthesis.
(Parse)
(S1 (S (NP (NN Immunotoxicity)) (ADVP (RB probably))
(VP (VBZ results)
(PP (IN from)
(NP (NN cell) (NN death)))
(PP (VBG following)
(NP (FW apoptosis) (CC and) (FW necrosis)))
(, ,)
(PP (IN in)
(NP (NP (NN combination))
(PP (IN with)
(NP (NP (JJ slow) (NN replacement))
(PP (IN of)
(NP (NP (JJ affected) (JJ immune) (NNS cells))
(ADJP (JJ due)
(PP (TO to)
(NP (NP (NN inhibition))
(PP (IN of)
(NP (NN protein) (NN synthesis))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Ruggenenti and his colleagues treated 50 patients withmembranous nephropathy with rituximab, which selectivelyreduces the effects of immune cells called B cells.
(Parse)
(S1 (S (NP (NP (NNP Ruggenenti)) (CC and)
(NP (PRP$ his) (NNS colleagues)))
(VP (VBN treated)
(NP (CD 50) (NNS patients))
(NP (JJ withmembranous) (NN nephropathy))
(PP (IN with)
(NP (NN rituximab)))
(, ,)
(SBAR (WHNP (WDT which))
(S (VP (VBZ selectivelyreduces)
(NP (NP (DT the) (NNS effects))
(PP (IN of)
(NP (NP (JJ immune) (NNS cells))
(VP (VBN called)
(S (NP (NNP B) (NNS cells)))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Crowe’s team was then able to isolate exceedingly rare B cells – the immune cells that produce antibodies – from eight of those samples and grow them in culture.
(Parse)
(S1 (S (NP (NP (NNP Crowe) (POS 's)) (NN team))
(VP (AUX was) (ADVP (RB then))
(ADJP (JJ able)
(S (VP (TO to)
(VP (VP (VB isolate)
(NP (NP (ADJP (RB exceedingly) (JJ rare)) (NNP B) (NNS cells)) (: -)
(NP (NP (DT the) (JJ immune) (NNS cells))
(SBAR (WHNP (WDT that))
(S (VP (VBP produce)
(NP (NNS antibodies)))
(: -))
(PP (IN from)
(NP (NP (CD eight))
(PP (IN of)
(NP (DT those) (NNS samples)))
(CC and)
(VP (VB grow)
(NP (PRP them))
(PP (IN in)
(NP (NN culture)))
(. .)))
In the ICWSM 2009 Weblog Corpus:
ScienceDaily (Aug. 25, 2008) – Researchers may be closer to understanding why anti-cancer drugs such as Ipilimumab, which boost the tumor – killing power of immune cells, haven’t fared well in clinical trials.
(Parse)
(S1 (S (NP (NP (NNP ScienceDaily)) (PRN (-LRB- -LRB-)
(NP (NNP Aug.) (CD 25) (, ,) (CD 2008)) (-RRB- -RRB-)) (: --)
(NP (NNP Researchers)))
(VP (MD may)
(VP (AUX be)
(ADJP (JJR closer)
(PP (TO to)
(S (VP (VBG understanding)
(SBAR (WHADVP (WRB why))
(S (NP (NP (JJ anti-cancer) (NNS drugs))
(PP (JJ such) (IN as)
(NP (NNP Ipilimumab)))
(, ,)
(SBAR (WHNP (WDT which))
(S (VP (VB boost)
(NP (NP (DT the) (NN tumor) (: -) (NN killing) (NN power))
(PP (IN of)
(NP (JJ immune) (NNS cells))))
(, ,))
(VP (AUX have) (RB n't)
(VP (VBN fared) (ADVP (RB well))
(PP (IN in)
(NP (JJ clinical) (NNS trials))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Crowe’s team was then able to isolate exceedingly rare B cells – the immune cells that produce antibodies – from eight of those samples and grow them in culture.
(Parse)
(S1 (S (NP (NP (NNP Crowe) (POS 's)) (NN team))
(VP (AUX was) (ADVP (RB then))
(ADJP (JJ able)
(S (VP (TO to)
(VP (VP (VB isolate)
(NP (NP (ADJP (RB exceedingly) (JJ rare)) (NNP B) (NNS cells)) (: -)
(NP (NP (DT the) (JJ immune) (NNS cells))
(SBAR (WHNP (WDT that))
(S (VP (VBP produce)
(NP (NNS antibodies)))
(: -))
(PP (IN from)
(NP (NP (CD eight))
(PP (IN of)
(NP (DT those) (NNS samples)))
(CC and)
(VP (VB grow)
(NP (PRP them))
(PP (IN in)
(NP (NN culture)))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Previous studies show that an enzyme within the cell, called telomerase, keeps immune cells young by preserving their telomere length and ability to continue dividing.
(Parse)
(S1 (S (NP (JJ Previous) (NNS studies))
(VP (VBP show)
(SBAR (IN that)
(S (NP (NP (DT an) (NN enzyme))
(PP (IN within)
(NP (DT the) (NN cell)))
(, ,)
(VP (VBN called)
(S (ADJP (JJ telomerase))))
(, ,))
(VP (VBZ keeps)
(S (NP (JJ immune) (NNS cells))
(ADJP (JJ young)
(PP (IN by)
(S (VP (VBG preserving)
(NP (PRP$ their) (JJ telomere) (NN length) (CC and) (NN ability))
(S (VP (TO to)
(VP (VB continue)
(S (VP (VBG dividing)))
(. .)))
In Wikipedia:
Factors promoting the differentiation of M cells have yet to be elucidated, but they are thought to develop in response to signals from immune cells found in the developing Peyer’s patch.
(Parse)
(S1 (S (S (NP (NP (NNS Factors))
(VP (VBG promoting)
(NP (NP (DT the) (NN differentiation))
(PP (IN of)
(NP (NNP M) (NNS cells)))
(VP (AUX have) (ADVP (RB yet))
(S (VP (TO to)
(VP (AUX be)
(VP (VBN elucidated))))
(, ,) (CC but)
(S (NP (PRP they))
(VP (AUX are)
(VP (VBN thought)
(S (VP (TO to)
(VP (VB develop)
(PP (IN in)
(NP (NP (NN response))
(PP (TO to)
(NP (NP (NNS signals))
(PP (IN from)
(NP (NP (JJ immune) (NNS cells))
(VP (VBN found)
(PP (IN in)
(NP (NP (DT the) (VBG developing) (NNP Peyer) (POS 's)) (NN patch))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
Immune cells absorb these proteins and, in turn, signal killer T cells to destroy pigment cells.
(Parse)
(S1 (S (NP (JJ Immune) (NNS cells))
(VP (VB absorb)
(NP (DT these) (NNS proteins)))
(CC and) (, ,)
(PP (IN in)
(NP (NN turn)))
(, ,)
(VP (VBP signal)
(NP (NN killer) (NNP T) (NNS cells))
(S (VP (TO to)
(VP (VB destroy)
(NP (NN pigment) (NNS cells)))
(. .)))
In the ICWSM 2009 Weblog Corpus:
How do the immune cells within the gut distinguish between potentially dangerous pathogens and harmless or beneficial commensal organisms? [Hint: It’s not through PAMPs (pathogen – associated molecular patterns.)] These investigators identified in mice a novel population of macrophages within the lamina propria, the layer of mucosa beneath the epithelium on the lumenal side of the intestine wall.
(Parse)
(S1 (FRAG (SBARQ (WHADVP (WRB How)) (SQ (AUX do)
(NP (NP (DT the) (JJ immune) (NNS cells))
(PP (IN within)
(NP (DT the) (NN gut))))
(VP (VB distinguish)
(PP (IN between)
(NP (NP (ADJP (RB potentially) (JJ dangerous)) (NNS pathogens)) (CC and)
(NP (ADJP (JJ harmless) (CC or) (JJ beneficial)) (JJ commensal) (NNS organisms)))
(. ?))
(NP (JJ -LSB-) (NN Hint)) (: :)
(S (NP (PRP It))
(VP (AUX 's) (RB not)
(PP (IN through)
(NP (NP (NNP PAMPs) (PRN (-LRB- -LRB-)
(NP (NP (NNS pathogen)) (: -)
(NP (JJ associated) (JJ molecular) (NNS patterns)) (. .)) (-RRB- -RRB-)) (NN -RSB-))
(SBAR (S (NP (DT These) (NNS investigators))
(VP (VBN identified)
(PP (IN in)
(NP (NNS mice)))
(NP (NP (DT a) (JJ novel) (NN population))
(PP (IN of)
(NP (NP (NNS macrophages))
(PP (IN within)
(NP (NP (DT the) (NN lamina) (NN propria)) (, ,)
(NP (NP (DT the) (NN layer))
(PP (IN of)
(NP (FW mucosa)))
(PP (IN beneath)
(NP (NP (DT the) (NN epithelium))
(PP (IN on)
(NP (NP (DT the) (JJ lumenal) (NN side))
(PP (IN of)
(NP (DT the) (JJ intestine) (NN wall)))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
In battles against chronic infections, the body’s key immune cells often become exhausted and ineffective.
(Parse)
(S1 (S (PP (IN In)
(NP (NP (NNS battles))
(PP (IN against)
(NP (JJ chronic) (NNS infections)))))
(, ,)
(NP (NP (DT the) (NN body) (POS 's)) (JJ key) (JJ immune) (NNS cells)) (ADVP (RB often))
(VP (VBP become)
(ADJP (JJ exhausted) (CC and) (JJ ineffective)))
(. .)))
In the ICWSM 2009 Weblog Corpus:
All cells in the body become stronger in response to the increased G force during rebounding, and this cellular exercise results in the self-propelled immune cells being up to 5 times more active.
(Parse)
(S1 (S (S (NP (NP (DT All) (NNS cells))
(PP (IN in)
(NP (DT the) (NN body))))
(VP (VBP become)
(ADJP (JJR stronger))
(PP (IN in)
(NP (NP (NN response))
(PP (TO to)
(NP (NP (DT the) (JJ increased) (NNP G) (NN force))
(PP (IN during)
(NP (VBG rebounding)))
(, ,) (CC and)
(S (NP (DT this) (JJ cellular) (NN exercise))
(VP (VBZ results)
(PP (IN in)
(NP (NP (DT the) (JJ self-propelled) (JJ immune) (NNS cells))
(VP (AUXG being)
(ADJP (QP (RP up) (TO to) (CD 5) (NNS times)) (RBR more) (JJ active))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
The researchers found that when TB infects specialized immune cells in the lungs called macrophages, it turns the cells into incubators, allowing TB bacteria to multiply.
(Parse)
(S1 (S (NP (DT The) (NNS researchers))
(VP (VBD found)
(SBAR (IN that)
(S (SBAR (WHADVP (WRB when))
(S (NP (NN TB))
(VP (VBZ infects)
(NP (NP (JJ specialized) (JJ immune) (NNS cells))
(PP (IN in)
(NP (DT the) (NNS lungs)))
(VP (VBD called)
(NP (NNS macrophages))))
(, ,)
(NP (PRP it))
(VP (VBZ turns)
(NP (DT the) (NNS cells))
(PP (IN into)
(NP (NNS incubators)))
(, ,)
(S (VP (VBG allowing)
(S (NP (NN TB) (NNS bacteria))
(VP (TO to)
(VP (VB multiply))))
(. .)))
In the ICWSM 2009 Weblog Corpus:
With the ability to become all of the blood cells? including your immune cells, red blood cells, all of your blood system, as well as vasculature? hemangioblasts have been biology’s holy grail.
(Parse)
(S1 (S (PP (IN With)
(NP (DT the) (NN ability)
(S (VP (TO to)
(VP (VB become)
(NP (NP (DT all))
(PP (IN of)
(NP (NP (DT the) (NN blood) (NNS cells) (. ?))
(PP (VBG including)
(NP (NP (PRP$ your) (JJ immune) (NNS cells)) (, ,)
(NP (JJ red) (NN blood) (NNS cells)) (, ,)
(NP (NP (DT all))
(PP (IN of)
(NP (PRP$ your) (NN blood) (NN system))))
(, ,) (CONJP (RB as) (RB well) (IN as))
(NP (JJ vasculature)))
(. ?))))
(NP (NNS hemangioblasts))
(VP (AUX have)
(VP (AUX been)
(NP (NP (NN biology) (POS 's)) (JJ holy) (NN grail))))
(. .)))
And 1,033 more sentences.